Skip to main content

Advertisement

Log in

Simple metabolic markers associated with tophaceous gout

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Introduction

The relationship between tophaceous gout and metabolic markers is not well understood. The aim of this study was to compare the correlations between different metabolic markers and tophi and evaluate their potential predictive values for tophus.

Method

We analysed the data of gout patients in Beijing Jishuitan Hospital from 2013 to 2020. Ten laboratory indicators (UA, eGFR, underexcretion, GLU, TRIG, HDL-C, ALT, TBIL, γ-GT and UPH) were included to evaluate the relationship between tophaceous gout and metabolic markers.

Results

Tophi was present in 14.7% (119/808) of gout patients. UA, eGFR, ALT and γ-GT were independently related to the development of tophi; UA and γ-GT were positively correlated. The γ-GT/ALT ratio and UA/eGFR ratio showed a positive correlation with tophi, with (rho, P) of (0.305, < 0.001) and (0.195, < 0.001), respectively. The γ-GT/ALT ratio showed the best classificatory performance (AUC = 0.749, P < 0.001) for tophi among the four positive correlation indicators. With increasing integer γ-GT/ALT ratio, the incidence of tophi (4.9%, 9.7%, 22.3% and 38.4%, P < 0.001), chronic kidney disease (2.5%, 5.2%, 12.3% and 19.2%, P < 0.001) and hyperuricemia over 10 years (6.6%, 10.7%, 18.5% and 26.4%, P < 0.001) showed a progressive increase. The γ-GT/ALT ratio was positively correlated with the number of tophi and duration of hyperuricemia, negatively correlated with eGFR.

Conclusions

UA, eGFR, γ-GT and ALT were independently associated with tophi. The γ-GT/ALT ratio may be used as a predictor or monitor of tophi.

Key Points

We found that UA, eGFR, γ-GT and ALT were independently related to tophi among clinical commonly indicators.

The γ-GT/ALT ratio performed best in the identification of tophaceous gout from gout.

The incidence of tophi and chronic kidney disease and duration of hyperuricemia increased with γ-GT/ALT ratio.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Data Availability

All data generated or analysed during this study are included in this published article and its supplementary information files.

Code availability

Not applicable.

References

  1. Danve A, Neogi T (2020) Rising global burden of gout: time to act. Arthritis Rheumatol 72:1786–1788. https://doi.org/10.1002/art.41453

    Article  PubMed  PubMed Central  Google Scholar 

  2. Khanna P, Johnson RJ, Marder B, LaMoreaux B, Kumar A (2020) Systemic urate deposition: an unrecognized complication of gout? J Clin Med 9.https://doi.org/10.3390/jcm9103204

  3. Thottam GE, Krasnokutsky S, Pillinger MH (2017) Gout and metabolic syndrome: a tangled web. Curr Rheumatol Rep 19:60. https://doi.org/10.1007/s11926-017-0688-y

    Article  PubMed  Google Scholar 

  4. Eslam M, Newsome PN, Sarin SK et al (2020) A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol 73:202–209. https://doi.org/10.1016/j.jhep.2020.03.039

    Article  PubMed  Google Scholar 

  5. Kuo CF, Yu KH, Luo SF et al (2010) Gout and risk of non-alcoholic fatty liver disease. Scand J Rheumatol 39:466–471. https://doi.org/10.3109/03009741003742797

    Article  CAS  PubMed  Google Scholar 

  6. Perez-Ruiz F, Martínez-Indart L, Carmona L, Herrero-Beites AM, Pijoan JI, Krishnan E (2014) Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout. Ann Rheum Dis 73:177–182. https://doi.org/10.1136/annrheumdis-2012-202421

    Article  CAS  PubMed  Google Scholar 

  7. Amanzada A, Goralczyk AD, Schneider S et al (2012) High predictability of a sustained virological response (87%) in chronic hepatitis C virus genotype 1 infection treatment by combined IL28B genotype analysis and γ-glutamyltransferase/alanine aminotransferase ratio: a retrospective single-center study. Digestion 86:218–227. https://doi.org/10.1159/000339879

    Article  CAS  PubMed  Google Scholar 

  8. Neogi T, Jansen TL, Dalbeth N et al (2015) 2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 74:1789–1798. https://doi.org/10.1136/annrheumdis-2015-208237

    Article  CAS  PubMed  Google Scholar 

  9. Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612. https://doi.org/10.7326/0003-4819-150-9-200905050-00006

    Article  PubMed  PubMed Central  Google Scholar 

  10. Lu B, Lu Q, Huang B, Li C, Zheng F, Wang P (2020) Risk factors of ultrasound-detected tophi in patients with gout. Clin Rheumatol 39:1953–1960. https://doi.org/10.1007/s10067-020-04947-2

    Article  PubMed  Google Scholar 

  11. Singh JA, Gaffo A (2020) Gout epidemiology and comorbidities. Semin Arthritis Rheum 50:S11-s16. https://doi.org/10.1016/j.semarthrit.2020.04.008

    Article  PubMed  Google Scholar 

  12. Battelli MG, Polito L, Bolognesi A (2014) Xanthine oxidoreductase in atherosclerosis pathogenesis: not only oxidative stress. Atherosclerosis 237:562–567. https://doi.org/10.1016/j.atherosclerosis.2014.10.006

    Article  CAS  PubMed  Google Scholar 

  13. Jung JH, Song GG, Ji JD et al (2018) Metabolic syndrome: prevalence and risk factors in Korean gout patients. Korean J Intern Med 33:815–822. https://doi.org/10.3904/kjim.2016.062

    Article  PubMed  Google Scholar 

  14. Bolzetta F, Veronese N, Manzato E, Sergi G (2012) Tophaceous gout in the elderly: a clinical case review. Clin Rheumatol 31:1127–1132. https://doi.org/10.1007/s10067-012-1956-x

    Article  PubMed  Google Scholar 

  15. Dalbeth N, Jones G, Terkeltaub R et al (2019) Efficacy and safety during extended treatment of lesinurad in combination with febuxostat in patients with tophaceous gout: CRYSTAL extension study. Arthritis Res Ther 21:8. https://doi.org/10.1186/s13075-018-1788-4

    Article  PubMed  PubMed Central  Google Scholar 

  16. Ma L, Sun R, Jia Z et al (2018) Clinical characteristics associated with subcutaneous tophi formation in Chinese gout patients: a retrospective study. Clin Rheumatol 37:1359–1365. https://doi.org/10.1007/s10067-017-3969-y

    Article  PubMed  Google Scholar 

  17. Corti A, Belcastro E, Dominici S, Maellaro E, Pompella A (2020) The dark side of gamma-glutamyltransferase (GGT): pathogenic effects of an “antioxidant” enzyme. Free Radic Biol Med 160:807–819. https://doi.org/10.1016/j.freeradbiomed.2020.09.005

    Article  CAS  PubMed  Google Scholar 

  18. Lee MY, Hyon DS, Huh JH et al (2019) Association between serum gamma-glutamyltransferase and prevalence of metabolic syndrome using data from the Korean Genome and Epidemiology Study. Endocrinol Metab (Seoul) 34:390–397. https://doi.org/10.3803/EnM.2019.34.4.390

    Article  CAS  Google Scholar 

  19. Wang G, Lu X, Du Q et al (2020) Diagnostic value of the γ-glutamyltransferase and alanine transaminase ratio, alpha-fetoprotein, and protein induced by vitamin K absence or antagonist II in hepatitis B virus-related hepatocellular carcinoma. Sci Rep 10:13519. https://doi.org/10.1038/s41598-020-70241-5

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Liu J, Xu C, Ying L et al (2017) Relationship of serum uric acid level with non-alcoholic fatty liver disease and its inflammation progression in non-obese adults. Hepatol Res 47:E104-e112. https://doi.org/10.1111/hepr.12734

    Article  CAS  PubMed  Google Scholar 

  21. Shen ZW, Xing J, Wang QL et al (2017) Association between serum γ-glutamyltransferase and chronic kidney disease in urban Han Chinese: a prospective cohort study. Int Urol Nephrol 49:303–312. https://doi.org/10.1007/s11255-016-1429-2

    Article  CAS  PubMed  Google Scholar 

  22. Sette LH, Lopes EP (2015) The reduction of serum aminotransferase levels is proportional to the decline of the glomerular filtration rate in patients with chronic kidney disease. Clinics (Sao Paulo) 70:346–349. https://doi.org/10.6061/clinics/2015(05)07

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Wei Liu, Hui Song, Siliang Man, Hongchao Li and Siming Gao carried out the studies, participated in collecting data and drafted the manuscript. Wei Liu, Hui Song and Siliang Man performed the statistical analysis and participated in its design. Wei Liu, Hongchao Li and Siming Gao helped to draft the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Hui Song.

Ethics declarations

Ethics approval

This project was approved by the Ethics Committee of Beijing Jishuitan Hospital (No. 202008–01).

Consent to participate

The informed consent was waived due to the retrospective nature of the study.

Consent for publication

Not applicable.

Disclosures

None.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, W., Song, H., Man, S. et al. Simple metabolic markers associated with tophaceous gout. Clin Rheumatol 40, 5047–5053 (2021). https://doi.org/10.1007/s10067-021-05861-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-021-05861-x

Keywords

Navigation